Benitec Biopharma Inc.
BNTC
$12.77
$0.191.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | 0.00 | -3.00K | -2.00K |
| Gross Profit | -- | -- | 0.00 | 3.00K | 2.00K |
| SG&A Expenses | 27.66M | 23.43M | 11.99M | 9.36M | 7.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.78M | 41.77M | 30.14M | 24.09M | 22.41M |
| Operating Income | -45.78M | -41.77M | -30.14M | -24.09M | -22.41M |
| Income Before Tax | -41.82M | -37.92M | -26.49M | -21.42M | -20.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -41.82 | -37.92 | -26.49 | -21.42 | -20.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.82M | -37.92M | -26.49M | -21.42M | -20.86M |
| EBIT | -45.78M | -41.77M | -30.14M | -24.09M | -22.41M |
| EBITDA | -45.72M | -41.70M | -30.06M | -24.00M | -22.31M |
| EPS Basic | -1.18 | -1.15 | -0.94 | -0.93 | -3.24 |
| Normalized Basic EPS | -0.74 | -0.72 | -0.59 | -0.58 | -2.02 |
| EPS Diluted | -1.18 | -1.15 | -0.94 | -0.93 | -3.24 |
| Normalized Diluted EPS | -0.74 | -0.72 | -0.59 | -0.58 | -2.02 |
| Average Basic Shares Outstanding | 143.35M | 129.72M | 114.39M | 94.07M | 74.57M |
| Average Diluted Shares Outstanding | 143.35M | 129.72M | 114.39M | 94.07M | 74.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |